Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

ZADITOR

KETOTIFEN FUMARATE

Standard Dose
EQ 0.025% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ZADITOR is listed in Drugs@FDA under application 021066 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient KETOTIFEN FUMARATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.025% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALCON PHARMA Submission history Latest submission status date: 2012-05-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZADITOR is listed in Drugs@FDA under application 021066 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient KETOTIFEN FUMARATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.025% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALCON PHARMA Submission history Latest submission status date: 2012-05-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.